Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

The Dermlep Study Part 2: Results of a Nation-Wide Survey of Dermatologists' Access to Quality Leprosy Services at their Clinics and Hospitals in India.

Rao NP, Rathod S, Suneetha S, et al. Indian dermatology online journal. 2020; 11 (6) : 895-903.
Download PDF
Publication

Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient's Quality of Life.

Mohta A, Agrawal A, Sharma P, et al. Indian dermatology online journal. 2020; 11 (6) : 959-964.
Download PDF
Publication

Clinico-epidemiological and histopathological study of newly diagnosed leprosy patients at tertiary care center

Baraithiya K, Kumar U, Varma K. IP Innovative Publication Pvt Ltd. IP Indian Journal of Clinical and Experimental Dermatology. 2020; 6 (4) : 374-381.
Download PDF
Publication

Clinical and microbiological profile of Hansen’s diseases in a tertiary care centre of southwest Bihar

Kumar M, Kumar D. IP Innovative Publication Pvt Ltd. IP Indian Journal of Clinical and Experimental Dermatology. 2020; 6 (4) : 361-365.
Download PDF
Publication

Leprosy perceptions and knowledge in endemic districts in India and Indonesia: differences and commonalities - Dataset

van 't Noordende A, Lisam S, Ruthindartri P, et al. 2021;
Publication

Verrucous lesions in leprosy.

Ashraf R, Narang T, Dogra S. International journal of mycobacteriology. 2020; 9 (4) : 445-447.
Download PDF
Publication

Reactive perforating leprosy: A rare case report of type 2 leprosy reaction.

Gunawan H, Nursjamsi N, Achdiat P, et al. International journal of mycobacteriology. 2020; 9 (4) : 451-453.
Download PDF
Publication

Spectrum of Inborn errors of immunity in a cohort of 90 patients presenting with complications to BCG vaccination in India.

Yadav R, Dalvi A, Gupta M, et al. Scandinavian journal of immunology. 2020;
Publication

Severe Type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences.

Saxena S, Khurana A, B S, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;
Download PDF
Publication

Gandhi’s Evolving Discourse on Leprosy

Kakar S. Springer International Publishing. Palgrave Studies in the History of the Media. 2020;

Pagination

  • Previous page ‹‹
  • Page 103
  • Next page ››
Subscribe to South-East Asia Region (SEAR)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD